Literature DB >> 19909870

When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

John B Gordon1, Andrew M Kahn, Jane C Burns.   

Abstract

Kawasaki disease (KD) is an acute, self-limited vasculitis that typically occurs in young children and was first described by Japanese pediatrician Tomisaku Kawasaki in 1967. Although originally thought to be a rare condition, KD has become the most common cause of acquired heart disease in the pediatric age group in developed countries. The majority of patients with KD appear to have a benign prognosis, but a subset of patients with coronary artery aneurysms are at risk for ischemic events and require lifelong treatment. In the 4 decades that have passed since the initial recognition of KD, the number of patients reaching adulthood has continued to grow. Adult cardiologists will be increasingly involved in the management of these patients. Currently, there are no established guidelines for the evaluation and treatment of adult patients who have had KD. We review here the current literature that may be helpful to clinicians who care for adults who experienced KD in childhood.

Entities:  

Mesh:

Year:  2009        PMID: 19909870      PMCID: PMC2870533          DOI: 10.1016/j.jacc.2009.04.102

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  97 in total

1.  Detectable silent calcification in a regressed coronary artery aneurysm of a young adult with a history of Kawasaki disease.

Authors:  J Muneuchi; K Joo; E Morihana; A Mizushima
Journal:  Pediatr Cardiol       Date:  2007-09-09       Impact factor: 1.655

2.  Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan.

Authors:  Etsuko Tsuda; Kazuya Kawamata; Reiko Neki; Shigeyuki Echigo; Yoshihide Chiba
Journal:  Cardiol Young       Date:  2006-04       Impact factor: 1.093

3.  Two adult cases of coronary artery aneurysms secondary to Kawasaki disease.

Authors:  A Kitamura; N Mukohara; N Ozaki; M Yoshida; T Shida
Journal:  Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 1.827

Review 4.  Long-term outcome of Kawasaki disease.

Authors:  Hideaki Senzaki
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

5.  Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.

Authors:  Yoko Sugahara; Masahiro Ishii; Hiromi Muta; Motofumi Iemura; Toyojiro Matsuishi; Hirohisa Kato
Journal:  Pediatr Cardiol       Date:  2007-11-20       Impact factor: 1.655

6.  Increasing incidence of Kawasaki disease in Japan: nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Kazunori Kayaba; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2008-06       Impact factor: 1.524

7.  Transthoracic echo-Doppler assessment of coronary microvascular function late after Kawasaki disease.

Authors:  S Cicala; M Galderisi; M Grieco; A Lamberti; R Cosimi; F Pellegrini; F de Leva
Journal:  Pediatr Cardiol       Date:  2007-08-28       Impact factor: 1.655

8.  Acute coronary artery dilation due to Kawasaki disease and subsequent late calcification as detected by electron beam computed tomography.

Authors:  S Kaichi; E Tsuda; H Fujita; K Kurosaki; R Tanaka; H Naito; S Echigo
Journal:  Pediatr Cardiol       Date:  2007-11-28       Impact factor: 1.655

9.  Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Makoto Watanabe; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2008-07-18       Impact factor: 3.211

Review 10.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

View more
  77 in total

1.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 2.  Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.

Authors:  Surjit Singh; Dhrubajyoti Sharma; Sagar Bhattad; Saji Phillip
Journal:  Indian J Pediatr       Date:  2015-08-30       Impact factor: 1.967

3.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

4.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

5.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

6.  Evaluation of left ventricular systolic strain in children with Kawasaki disease.

Authors:  Qiu-Qin Xu; Yue-Yue Ding; Hai-Tao Lv; Wan-Ping Zhou; Ling Sun; Jie Huang; Wen-Hua Yan
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

7.  Bioresorbable Vascular Scaffold Implantation for Successful Treatment of a Symptomatic Coronary Lesion in a 17-Year-Old Boy After Kawasaki Disease.

Authors:  Brigitte Luu; Anoosh Esmaeili; Dietmar Schranz; Stephan Fichtlscherer
Journal:  Pediatr Cardiol       Date:  2015-06-11       Impact factor: 1.655

8.  Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.

Authors:  Mansingh Parihar; Surjit Singh; Pandiarajan Vignesh; Anju Gupta; Manojkumar Rohit
Journal:  Pediatr Cardiol       Date:  2017-05-17       Impact factor: 1.655

9.  Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin.

Authors:  Adriana H Tremoulet; Sonia Jain; Jane C Burns
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-13       Impact factor: 0.694

10.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.